Ovine Kidney Extract (Ovis aries)
Ovine kidney extract is a glandular supplement derived from sheep (Ovis aries) kidney tissue, theorized to contain organ-specific proteins, peptides, and cofactors such as coenzyme Q10 and cytochrome enzymes. No human clinical trials have validated therapeutic benefits, and existing research on sheep kidneys focuses on pharmacokinetic modeling and toxin accumulation rather than supplementation.

Origin & History
Ovine Kidney Extract is derived from the kidneys of sheep (Ovis aries), a domestic ruminant species. No standardized extraction methods for supplement use are documented in available sources; analytical preparations involve thin slicing, drying for 2-3 weeks, and powdering, but commercial extraction processes remain undefined.
Historical & Cultural Context
No historical or traditional medicinal uses of ovine kidney extract are documented in the available research sources. Current studies focus exclusively on veterinary pharmacology and environmental contamination assessment.
Health Benefits
• No clinically proven health benefits - no human trials exist • No evidence for kidney support - research limited to drug pharmacokinetics in sheep • No documented effects on renal function - studies focus on toxin accumulation not therapeutic use • No established nutritional benefits - active compounds remain unidentified • No traditional medicinal applications documented in available sources
How It Works
Proponents of glandular therapy hypothesize that organ-specific peptides and growth factors within ovine kidney tissue may exert organotropic effects on human renal cells, though no receptor-binding studies confirm this. The extract theoretically contains mitochondrial cofactors such as coenzyme Q10 and cytochrome c oxidase subunits relevant to renal tubular energy metabolism, but bioavailability following oral ingestion remains undemonstrated. Digestive proteolysis of larger peptides into amino acid fragments renders most proposed bioactive compounds pharmacologically inert before systemic absorption.
Scientific Research
No human clinical trials, RCTs, or meta-analyses on ovine kidney extract were identified. Available research is limited to veterinary pharmacokinetics (ertapenem clearance in sheep, PMC6807722) and environmental toxicology studies examining uranium accumulation in sheep kidneys near mining sites, with no clinical applications.
Clinical Summary
No published human clinical trials exist examining ovine kidney extract as a dietary supplement for any health outcome. Research involving sheep kidney tissue is confined to veterinary pharmacokinetic studies, such as modeling antibiotic residue clearance, and environmental toxicology studies documenting heavy metal and mycotoxin accumulation in renal cortex tissue. The absence of randomized controlled trials, dose-response data, or bioavailability studies means no quantified therapeutic outcomes can be cited. Evidence strength is rated negligible, placing this ingredient among the least-studied glandular extracts on the market.
Nutritional Profile
Ovine kidney extract, derived from sheep (Ovis aries) kidneys, shares a broadly similar compositional profile to other mammalian kidney tissue extracts. Protein content is the dominant macronutrient, estimated at 16–18g per 100g of fresh kidney tissue equivalent, comprising complete proteins with all essential amino acids including lysine (~1.8g/100g), leucine (~1.5g/100g), and arginine (~1.1g/100g). Fat content is relatively low at approximately 3–4g/100g, with a mixed fatty acid profile including oleic acid, palmitic acid, and small amounts of arachidonic acid. Carbohydrate content is minimal (<1g/100g). Micronutrient composition is notably rich in B-vitamins characteristic of organ tissue: cobalamin (B12) estimated at 25–30µg/100g (>1000% RDI), riboflavin (B2) at approximately 1.8–2.2mg/100g, niacin (B3) at 7–9mg/100g, and pantothenic acid at 3–4mg/100g. Mineral content includes iron (4–6mg/100g, predominantly heme iron with high bioavailability ~25–30%), zinc (2–3mg/100g), selenium (100–150µg/100g, reflecting sheep's selenium-rich pasture diet), phosphorus (200–250mg/100g), and copper (0.3–0.5mg/100g). Bioactive compounds include coenzyme Q10 (estimated 2–4mg/100g), creatine, taurine (~200–400mg/100g), and carnitine. As a concentrated extract, these values scale proportionally to extraction ratio. Bioavailability of micronutrients may be altered depending on extraction methodology (aqueous vs. lipid-based). No standardized extract concentration data exists in peer-reviewed literature.
Preparation & Dosage
No clinically studied dosage ranges, forms, or standardization details are available as no human studies exist. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
None identified due to lack of research
Safety & Interactions
Ovine kidney tissue is a known accumulator of heavy metals including cadmium and lead, as well as mycotoxins such as ochratoxin A, raising contamination concerns depending on sourcing and quality controls. Individuals with prion disease risk sensitivity or immunocompromised status should exercise caution with any ruminant glandular product due to theoretical prion transmission risk, though commercial processing aims to mitigate this. No formal drug interaction data exist, but the theoretical presence of biologically active peptides warrants caution alongside immunosuppressants or nephrotoxic medications. Pregnancy and lactation safety is entirely unstudied and use is not recommended during these periods.